ABOUT TELIX

Telix was created to deliver on the promise of nuclear medicine.


Telix is a biopharmaceutical company focused on the development and commercialisation of diagnostic and therapeutic (‘theranostic’) products using molecularly targeted radiation (MTR). Nuclear medicine is finally coming of age, with commercial critical mass building and commitment to late-stage product development. Our goal is to harness this momentum for the benefit of patients, with MTR potentially offering better-informed treatment decisions and truly personalised therapy.

Telix’s product development strategy is to closely integrate and add value to standard care, reflective of the modern team-based approach to managing cancer.

Telix’s lead product, Illuccix® (kit for the preparation of gallium Ga 68 gozetotide injection), also known as 68Ga PSMA-11 injection, has been approved by the U.S. Food and Drug Administration (FDA), and by the Australian Therapeutic Goods Administration (TGA). Telix is also progressing marketing authorisation applications for this investigational candidate in Canada and Europe.

Telix’s research pipeline aims to address significant unmet medical need in prostate, kidney, brain (glioblastoma), and hematologic cancers as well as a range of immunologic and rare diseases. We are also keenly interested in partnership and in-licensing opportunities to further expand our portfolio.

Telix is headquartered in Melbourne, Australia with international operations in Belgium, Japan, Switzerland, and the United States. In 2020, Telix acquired a production facility in Seneffe, Belgium, with one of the broadest private sector medical isotope licences in Europe. This delivers significant operational flexibility, and ensures the ability to meet commercial production requirements in Europe.

Our Purpose
We help people with cancer and rare diseases live longer, better quality lives.
Our Mission
To deliver on the promise of precision medicine through targeted radiation.

Our Values

Our Values

Everyone counts

We put patients and our people first.

We respect and value diversity and individuality.

We foster a culture of collaboration, where all voices are heard.

We strive to be extraordinary

We explore the possibilities and celebrate learning and success.

We are courageous and embrace challenge.

We use our talents and knowledge to create a better future.

We pursue our goals with determination and integrity

We take responsibility for our words, our actions and our results.

A commitment to quality and safety underpins everything we do.

We strive for excellence in every action, every day.

In doing this, we create value for our shareholders.